The ultimate opportunity for advancing pharmacy practice

NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet 2016;389:37-55.

Mendis S Puska P Norrving B editors. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011.

Padwal RS Bienek A McAlister FA Campbell NRC , for the Outcomes Research Task Force of the Canadian Hypertension Education Program. Epidemiology of hypertension in Canada: an update. Can J Cardiol 2016:32:687-94.

Lim SS Vos T Flaxman AD . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60.

Santschi V Chiolero A Colosimo AL . Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc 2014;3(2):e000718.

Tsuyuki RT Houle SK Charrois TL . Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta Clinical Trial in Optimizing Hypertension (R_xACTION). Circulation 2015;132(2):93-100.

Marra C Johnston K Santschi V Tsuyuki RT . Cost-effectiveness of pharmacist care for managing hypertension in Canada. Can Pharm J (Ott) 2017;150(3):184-97.

Broadstreet Health Economics & Outcomes Research. Improving health and lowering costs: benefits of pharmacist care in hypertension in Canada. Ottawa (ON): Canadian Pharmacists Association; 2017. Available: https://www.pharmacists.ca/cpha-ca/assets/File/cpha-on-the-issues/Benefits_of_Pharmacist_Care_in_Hypertension_EN.pdf (accessed May 9, 2017).

Hypertension Canada. Mission and vision. Available: https://www.hypertension.ca/en/mission-and-vision (accessed May 9, 2017).